This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Chinook Therapeutics, Inc., Aduro Biotech Inc., Novartis Ag. Active years: 2019-2021.
Company Filing History:
2 out of 10 
1 out of 29 
1 out of 3,974 
Years Active: 2019-2021
Title: Kelsey Gauthier: Innovator in Immune Stimulation
Introduction
Kelsey Gauthier is a prominent inventor based in Alameda, CA (US). She has made significant contributions to the field of immune stimulation, holding a total of 3 patents. Her work focuses on developing compositions and methods that enhance immune responses through innovative mechanisms.
Latest Patents
Gauthier's latest patents include groundbreaking inventions related to the activation of the 'stimulator of interferon gene' (STING) dependent signaling. One of her notable inventions provides highly active cyclic-di-nucleotide (CDN) immune stimulators that activate dendritic cells (DCs) via the STING receptor. The compositions she developed comprise one or more cyclic purine dinucleotides that induce human STING-dependent type I interferon production. These cyclic purine dinucleotides are specifically designed to be 2'-fluoro substituted, bis-3′,5′ CDNs, and include 2′,2′-diF-Rp,Rp, bis-3′,5′CDNs.
Career Highlights
Throughout her career, Kelsey Gauthier has worked with notable companies such as Chinook Therapeutics, Inc. and Aduro Biotech Inc. Her expertise in immune stimulation has positioned her as a valuable asset in the biotechnology sector.
Collaborations
Gauthier has collaborated with esteemed colleagues, including George Edwin Katibah and David Braun Kanne. These partnerships have furthered her research and development efforts in the field of immunology.
Conclusion
Kelsey Gauthier's innovative work in immune stimulation and her impressive portfolio of patents highlight her significant contributions to the field. Her ongoing research continues to pave the way for advancements in immune therapies.